These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16170360)

  • 1. Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth.
    Bhonde MR; Hanski ML; Notter M; Gillissen BF; Daniel PT; Zeitz M; Hanski C
    Oncogene; 2006 Jan; 25(2):165-75. PubMed ID: 16170360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status.
    Magrini R; Bhonde MR; Hanski ML; Notter M; Scherübl H; Boland CR; Zeitz M; Hanski C
    Int J Cancer; 2002 Sep; 101(1):23-31. PubMed ID: 12209584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis.
    Bhonde MR; Hanski ML; Budczies J; Cao M; Gillissen B; Moorthy D; Simonetta F; Scherübl H; Truss M; Hagemeier C; Mewes HW; Daniel PT; Zeitz M; Hanski C
    J Biol Chem; 2006 Mar; 281(13):8675-85. PubMed ID: 16446370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines.
    te Poele RH; Joel SP
    Br J Cancer; 1999 Dec; 81(8):1285-93. PubMed ID: 10604724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN-38.
    Bhonde MR; Hanski ML; Stehr J; Jebautzke B; Peiró-Jordán R; Fechner H; Yokoyama KK; Lin WC; Zeitz M; Hanski C
    Int J Cancer; 2010 Jun; 126(12):2813-25. PubMed ID: 19739070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer effect of SN-38 on colon cancer cell lines with different metastatic potential.
    Wallin A; Svanvik J; Holmlund B; Ferreud L; Sun XF
    Oncol Rep; 2008 Jun; 19(6):1493-8. PubMed ID: 18497955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
    Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A
    Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.
    McDonald AC; Brown R
    Br J Cancer; 1998 Sep; 78(6):745-51. PubMed ID: 9743293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines.
    Crea F; Giovannetti E; Cortesi F; Mey V; Nannizzi S; Gallegos Ruiz MI; Ricciardi S; Del Tacca M; Peters GJ; Danesi R
    Mol Cancer Ther; 2009 Jul; 8(7):1964-73. PubMed ID: 19531575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
    Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y
    Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin.
    Han Z; Wei W; Dunaway S; Darnowski JW; Calabresi P; Sedivy J; Hendrickson EA; Balan KV; Pantazis P; Wyche JH
    J Biol Chem; 2002 May; 277(19):17154-60. PubMed ID: 11877436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe.
    Tse AN; Schwartz GK
    Cancer Res; 2004 Sep; 64(18):6635-44. PubMed ID: 15374978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule.
    Soares J; Raimundo L; Pereira NA; Monteiro Â; Gomes S; Bessa C; Pereira C; Queiroz G; Bisio A; Fernandes J; Gomes C; Reis F; Gonçalves J; Inga A; Santos MM; Saraiva L
    Oncotarget; 2016 Jan; 7(4):4326-43. PubMed ID: 26735173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of G2 arrest on the cytotoxicity of DNA topoisomerase inhibitors toward human carcinoma cells with different p53 status.
    Bozko P; Larsen AK; Raymond E; Skladanowski A
    Acta Biochim Pol; 2002; 49(1):109-19. PubMed ID: 12136930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection.
    Nagasawa H; Keng P; Maki C; Yu Y; Little JB
    Cancer Res; 1998 May; 58(9):2036-41. PubMed ID: 9581850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
    Wang S; El-Deiry WS
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wee1 inhibition can suppress tumor proliferation and sensitize p53 mutant colonic cancer cells to the anticancer effect of irinotecan.
    Yin Y; Shen Q; Tao R; Chang W; Li R; Xie G; Liu W; Zhang P; Tao K
    Mol Med Rep; 2018 Feb; 17(2):3344-3349. PubMed ID: 29257266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan induces cell cycle arrest, but not apoptosis or necrosis, in Caco-2 and CW2 colorectal cancer cell lines.
    Kaku Y; Tsuchiya A; Kanno T; Nishizaki T
    Pharmacology; 2015; 95(3-4):154-9. PubMed ID: 25833236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage-induced cell cycle checkpoints involve both p53-dependent and -independent pathways: role of telomere repeat binding factor 2.
    Narayan S; Jaiswal AS; Multani AS; Pathak S
    Br J Cancer; 2001 Sep; 85(6):898-901. PubMed ID: 11556843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
    Davidson D; Wang Y; Aloyz R; Panasci L
    Invest New Drugs; 2013 Apr; 31(2):461-8. PubMed ID: 23054213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.